These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24520215)

  • 1. Fatty acid synthase mediates the epithelial-mesenchymal transition of breast cancer cells.
    Li J; Dong L; Wei D; Wang X; Zhang S; Li H
    Int J Biol Sci; 2014; 10(2):171-80. PubMed ID: 24520215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of fatty acid synthase in drug tolerance related to epithelial-mesenchymal transition of breast cancer.
    Li JQ; Xue H; Zhou L; Dong LH; Wei DP; Li H
    Asian Pac J Cancer Prev; 2014; 15(18):7617-23. PubMed ID: 25292037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype.
    Zhou C; Nitschke AM; Xiong W; Zhang Q; Tang Y; Bloch M; Elliott S; Zhu Y; Bazzone L; Yu D; Weldon CB; Schiff R; McLachlan JA; Beckman BS; Wiese TE; Nephew KP; Shan B; Burow ME; Wang G
    Breast Cancer Res; 2008; 10(6):R105. PubMed ID: 19087274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel positive feedback loop involving FASN/p-ERK1/2/5-LOX/LTB4/FASN sustains high growth of breast cancer cells.
    Hu N; Li Y; Zhao Y; Wang Q; You JC; Zhang XD; Ye LH
    Acta Pharmacol Sin; 2011 Jul; 32(7):921-9. PubMed ID: 21643005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of fatty acid synthase and adipocyte fatty acid-binding protein and the relationship with the clinicopathological characteristics in human infiltrating ductal breast cancer].
    Zhou L; Zhao YH; Wang XD; Jiang SF; Li H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):228-33. PubMed ID: 25924435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fatty acid synthase inhibitors on lymphatic vessels: an in vitro and in vivo study in a melanoma model.
    Bastos DC; Paupert J; Maillard C; Seguin F; Carvalho MA; Agostini M; Coletta RD; Noël A; Graner E
    Lab Invest; 2017 Feb; 97(2):194-206. PubMed ID: 27918556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid synthase affects expression of ErbB receptors in epithelial to mesenchymal transition of breast cancer cells and invasive ductal carcinoma.
    Chen T; Zhou L; Li H; Tian Y; Li J; Dong L; Zhao Y; Wei D
    Oncol Lett; 2017 Nov; 14(5):5934-5946. PubMed ID: 29113229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of endogenous lipogenesis induces reversion of the malignant phenotype and normalized differentiation in breast cancer.
    Gonzalez-Guerrico AM; Espinoza I; Schroeder B; Park CH; Kvp CM; Khurana A; Corominas-Faja B; Cuyàs E; Alarcón T; Kleer C; Menendez JA; Lupu R
    Oncotarget; 2016 Nov; 7(44):71151-71168. PubMed ID: 27223424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis.
    Liu F; Zhang H; Song H
    Oncol Rep; 2017 Jan; 37(1):83-90. PubMed ID: 27878304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual inhibition of MEK1/2 and MEK5 suppresses the EMT/migration axis in triple-negative breast cancer through FRA-1 regulation.
    Hoang VT; Matossian MD; La J; Hoang K; Ucar DA; Elliott S; Burks HE; Wright TD; Patel S; Bhatt A; Phamduy T; Chrisey D; Buechlein A; Rusch DB; Nephew KP; Anbalagan M; Rowan B; Cavanaugh JE; Flaherty PT; Miele L; Collins-Burow BM; Burow ME
    J Cell Biochem; 2021 Aug; 122(8):835-850. PubMed ID: 33876843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid synthase inhibitors induce apoptosis in non-tumorigenic melan-a cells associated with inhibition of mitochondrial respiration.
    Rossato FA; Zecchin KG; La Guardia PG; Ortega RM; Alberici LC; Costa RA; Catharino RR; Graner E; Castilho RF; Vercesi AE
    PLoS One; 2014; 9(6):e101060. PubMed ID: 24964211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FASN, ErbB2-mediated glycolysis is required for breast cancer cell migration.
    Zhou L; Jiang S; Fu Q; Smith K; Tu K; Li H; Zhao Y
    Oncol Rep; 2016 May; 35(5):2715-22. PubMed ID: 26936618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Fatty Acid Synthase (FASN) synergistically enhances the efficacy of 5-fluorouracil in breast carcinoma cells.
    Vazquez-Martin A; Ropero S; Brunet J; Colomer R; Menendez JA
    Oncol Rep; 2007 Oct; 18(4):973-80. PubMed ID: 17786362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.
    Pavan S; Meyer-Schaller N; Diepenbruck M; Kalathur RKR; Saxena M; Christofori G
    Oncogene; 2018 Aug; 37(31):4197-4213. PubMed ID: 29713055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
    Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
    Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
    Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
    Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mTOR inhibitor rapamycin synergizes with a fatty acid synthase inhibitor to induce cytotoxicity in ER/HER2-positive breast cancer cells.
    Yan C; Wei H; Minjuan Z; Yan X; Jingyue Y; Wenchao L; Sheng H
    PLoS One; 2014; 9(5):e97697. PubMed ID: 24866893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor receptor-1 activation promotes migration and invasion of breast cancer cells through epithelial-mesenchymal transition.
    Ning Q; Liu C; Hou L; Meng M; Zhang X; Luo M; Shao S; Zuo X; Zhao X
    PLoS One; 2013; 8(6):e65217. PubMed ID: 23776453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A FASN-TGF-β1-FASN regulatory loop contributes to high EMT/metastatic potential of cisplatin-resistant non-small cell lung cancer.
    Yang L; Zhang F; Wang X; Tsai Y; Chuang KH; Keng PC; Lee SO; Chen Y
    Oncotarget; 2016 Aug; 7(34):55543-55554. PubMed ID: 27765901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF‑β1‑induced epithelial‑mesenchymal transition increases fatty acid oxidation and OXPHOS activity via the p‑AMPK pathway in breast cancer cells.
    Liu QQ; Huo HY; Ao S; Liu T; Yang L; Fei ZY; Zhang ZQ; Ding L; Cui QH; Lin J; Yu M; Xiong W
    Oncol Rep; 2020 Sep; 44(3):1206-1215. PubMed ID: 32705260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.